Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Other Operating Expenses (2022 - 2025)

Bioregenx (BRGX) has 4 years of Other Operating Expenses data on record, last reported at $2316.0 in Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 99.86% year-over-year to $2316.0; the TTM value through Sep 2025 reached $16.8 million, up 788.7%, while the annual FY2024 figure was $18.6 million, 3829.77% up from the prior year.
  • Other Operating Expenses reached $2316.0 in Q3 2025 per BRGX's latest filing, down from $2987.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $16.8 million in Q4 2024 and bottomed at $2316.0 in Q3 2025.
  • Average Other Operating Expenses over 4 years is $1.3 million, with a median of $54658.0 recorded in 2024.
  • Peak YoY movement for Other Operating Expenses: surged 18770.95% in 2024, then crashed 99.86% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $7686.0 in 2022, then surged by 1056.27% to $88871.0 in 2023, then soared by 18770.95% to $16.8 million in 2024, then tumbled by 99.99% to $2316.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $2316.0 in Q3 2025, $2987.0 in Q2 2025, and $8278.0 in Q1 2025.